Lipid-lowering therapies: Better together

Affiliations

¹ Department of Hypertension, Medical University of Lodz (MUL), Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciej.banach@iczmp.edu.pl.
² School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK; Liverpool Centre for Cardiovascular Science, Liverpool, UK.

Editorial

Maciej Banach et al. Atherosclerosis. 2021 Mar.

. 2021 Mar:320:86-88.

doi: 10.1016/j.atherosclerosis.2021.01.009. Epub 2021 Jan 12.

¹ Department of Hypertension, Medical University of Lodz (MUL), Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciej.banach@iczmp.edu.pl.
² School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK; Liverpool Centre for Cardiovascular Science, Liverpool, UK.

No abstract available

Keywords: Bempedoic acid; Combination therapy; Lipid-lowering therapy; Statins.

Comment on

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial.
Rubino J, MacDougall DE, Sterling LR, Hanselman JC, Nicholls SJ. Rubino J, et al. Atherosclerosis. 2021 Mar;320:122-128. doi: 10.1016/j.atherosclerosis.2020.12.023. Epub 2020 Dec 31. Atherosclerosis. 2021. PMID: 33514449 Clinical Trial.